Scientific Highlights

Datum
SLS

Thank You SLS

Our beamline scientists look back on 22 years of brilliant science made possible by the Swiss Light Source SLS.

Weiterlesen
nanobodies

Nanobodies against SARS-CoV-2

In a study published in EMBO Journal, researchers at the Max Planck Institute for Biophysical Chemistry, Göttingen, Germany, developed nanobodies that efficiently block the coronavirus SARS-CoV-2 and its variants. The high resolution structural characterization was performed at the X10SA crystallography beamline at the Swiss Light Source.

Weiterlesen
SARS-CoV-2_orf9b

Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions

In a study published in Nature Communications, researchers at the NHC Key Laboratory of Systems Biology of Pathogens in Beijing, China, in collaboration with the Paul Scherrer Institut characterize the interactions of SARS-CoV-2 orf9b and human TOM70 biochemically, and they determine the 2.2 Å crystal structure of the TOM70 cytosolic domain with a bound SARS-CoV-2 orf9b peptide.

Weiterlesen
Teaser Remdesivir

How remdesivir works against the coronavirus

Health Innovation Medical Science Research on Covid-19

Researchers at Goethe University Frankfurt, in cooperation with the PSI have probably discovered another, previously unknown mechanism of action of the antiviral remdesivir.

Weiterlesen
darobactin

Combating antimicrobial resistance

In a study addressing the global health threat of drug resistance, researchers at the Biozentrum, University of Basel, have revealed how a new antibiotic, Darobactin, binds to the external membrane of gram-negative bacteria.

Weiterlesen
Dikic lab

First MX results of the priority COVID-19 call

The Dikic group at the Goethe University in Frankfurt am Main, Germany has published the first results following the opening of the "PRIORITY COVID-19 Call” at SLS. 

Weiterlesen